Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PROFthis companyProfound Medical Corp.	$7.30	-5.5×	2.61×	14.53×	-3.93×	-434.1%	70.8%	-256.3%	-264.4%	-47.6%	-22.7%	-16.4%	0.07×	1.82×	0×	12.52×	0.0%	3	9.01	1	C-
APTX.TOApotex Health Corp.	CA$34.79	16.77×	-11.21×	1.79×	10.66×	345.4%	55.6%	22.5%	10.7%	-67.0%	17.6%	7.3%	-6.31×	3.8×	3.24×	1.5×	17.7%	—	—	—	—
BLCO.TOBausch + Lomb Corporation	CA$28.19	-16.74×	0.94×	1.18×	18.09×	-58.7%	54.8%	3.7%	-7.1%	-5.6%	1.5%	-1.1%	0.83×	8.17×	0.45×	1.55×	0.0%	5	1.13	1	C-
BLCOBausch + Lomb Corporation	$20.10	-16.75×	0.94×	1.18×	20.62×	-65.1%	54.8%	3.7%	-7.1%	-5.6%	1.5%	-1.1%	0.83×	9.32×	0.44×	1.55×	0.0%	5	1.05	1	C-
ABCLAbCellera Biologics Inc.	$11.79	-6.98×	1.06×	13.6×	-6.97×	-113.4%	61.6%	-289.0%	-194.9%	-15.1%	-13.8%	-17.0%	0.15×	-0.1×	0×	11.32×	0.0%	3	5.23	2	C
XENEXenon Pharmaceuticals Inc.	$39.52	-10.28×	6.11×	473.62×	-9.82×	-93.5%	66.1%	-4974.3%	-4612.1%	-59.5%	-39.6%	-7.9%	0.01×	0.56×	0×	13.42×	0.0%	2	39.15	2	C
Peer median	—	-10.28×	0.94×	1.79×	10.66×	-65.1%	55.6%	3.7%	-7.1%	-15.1%	1.5%	-1.1%	0.15×	3.8×	0.44×	1.55×	0.0%	4	3.18	2	—